Blue Owl Capital Holdings LP

Position in CNTX — Context Therapeutics Inc.

CIK 1858703 New York, NY

Position in CNTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,625,444

-$11,707,775 QoQ

Shares Held

2,934,015

-42.3% QoQ

Ownership

3.19%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

of 79 holders

Holding Since

Jun 2024

9 quarters on record

Healthcare · as of Jun 30, 2026

Blue Owl Capital Holdings LP holds $278,984,828 across 30 Biotechnology names. CNTX ranks #21 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AKTS	Aktis Oncology, Inc.	3,070,219	$98,953,158
2	CGEM	Cullinan Therapeutics, Inc.	1,539,764	$28,039,102
3	LRMR	Larimar Therapeutics, Inc.	9,163,157	$27,947,628
4	MPLT	MapLight Therapeutics, Inc.	729,929	$26,160,655
5	EYPT	EyePoint, Inc.	762,594	$10,905,094
6	SGMT	Sagimet Biosciences Inc.	1,260,544	$9,744,005
7	CRVS	Corvus Pharmaceuticals, Inc.	608,600	$9,092,484
8	ARTV	Artiva Biotherapeutics, Inc.	874,542	$8,483,057

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,625,444	2,934,015	-42.3%	Shares	Defined	2026-08-11
2026-06-30	$1,625,444	2,934,015	—	Shares	Sole	2026-08-12
2026-03-31	$13,333,219	5,089,015	-31.5%	Shares	Defined	2026-05-14
2025-12-31	$10,926,371	7,432,906	+0.3%	Shares	Defined	2026-02-20
2025-09-30	$7,178,260	7,407,906	0.0%	Shares	Defined	2025-11-12
2025-06-30	$4,852,178	7,407,906	+0.5%	Shares	Defined	2025-08-11
2025-03-31	$4,509,158	7,367,906	+15.9%	Shares	Defined	2025-05-15
2024-12-31	$6,675,824	6,357,928	+17.5%	Shares	Defined	2025-02-14
2024-09-30	$10,606,128	5,411,290	+4.8%	Shares	Defined	2024-11-14
2024-06-30	$10,348,386	5,161,290	—	Shares	Defined	2024-08-15
No filing history on record for this holder in this stock.